Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280366 · ClinicalTrials.gov registry record · NA
STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma
A NA study of Open Angle Glaucoma, sponsored by New World Medical.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT05280366 is a NA study of Open Angle Glaucoma that is active but no longer recruiting, run by New World Medical. The registered enrollment target is 150 participants, below the 329-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (54% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT05280366, a NA study of Open Angle Glaucoma, is active but no longer recruiting, sponsored by New World Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study of the Streamline Surgical System versus competitor
Conditions Studied
Interventions
- DEVICE Streamline Surgical System
- DEVICE iStent Inject W
Study Locations (20)
Texas
- Ophthalmology Associates - Fort Worth
- Berkely Eye Center - Houston
- R & R Eye Research - San Antonio
California
- Visionary Research Institute - Newport Beach
- Wolstan and Goldberg Eye Associates - Torrance
New Jersey
- Eye Associates of North New Jersey - Dover
- Eye Associates Surgical Center - Vineland
Other
- Clinica 20/20 - San José
- Clinica Laser y Ultrasonido Ocular - Puebla City
Arkansas
- Vold Vision - Fayetteville
Colorado
- University of Colorado - Aurora
Florida
- Ocala Eye - Ocala
Georgia
- Georgia Eye Partners - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280366
The ClinicalTrials.gov registry entry for NCT05280366 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 329-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target (54% lower). The listed sponsor is New World Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Streamline Surgical System is the first listed.
NCT05280366 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Texas, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05280366 about?
NCT05280366 is a clinical study titled "STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma". A study of the Streamline Surgical System versus competitor
What is the current status of trial NCT05280366?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-02-09. Estimated completion is 2026-06-30.
What conditions does trial NCT05280366 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
What interventions are being tested in trial NCT05280366?
The interventions under investigation include: Streamline Surgical System (DEVICE), iStent Inject W (DEVICE).
Who is sponsoring clinical trial NCT05280366?
This trial is sponsored by New World Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05280366 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Surgical Treatment of Refractory Open Angle Glaucoma
COMPLETED · NA
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.